Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA

Abstract

Huntington disease (HD) is an adult-onset, autosomal dominant inherited human neurodegenerative disorder characterized by hyperkinetic involuntary movements, including motor restlessness and chorea, slowing of voluntary movements and cognitive impairment. Selective regional neuron loss and gliosis in striatum, cerebral cortex, thalamus, subthalamus and hippocampus 1,2,3,4 are well recognized as neuropathological correlates for the clinical manifestations of HD. The underlying genetic mutation is the expansion of CAG trinucleotide repeats (coding for polyglutamines) to 36-121 copies in exon 1 of the HD gene 5,6,7,8. The HD mRNA and protein product (huntingtin) show widespread distribution9,10,11, and thus much remains to be understood about the selective and progressive neurodegeneration in HD. To create an experimental animal model for HD, transgenic mice were generated showing widespread expression of full-length human HD cDNA with either 16, 48 or 89 CAG repeats. Only mice with 48 or 89 CAG repeats manifested progressive behavioural and motor dysfunction with neuron loss and gliosis in striatum, cerebral cortex, thalamus and hippocampus. These animals represent clinically relevant models for HD pathogenesis, and may provide insights into the underlying pathophysiological mechanisms of other triplet repeat disorders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Transgenic analysis.
Figure 2: Comparative sections of human and mouse striatum.
Figure 3: Neurodegeneration in HD transgenic mice.
Figure 4: Apoptosis in HD transgenic mice.
Figure 5: Immunoreactivity with anti-huntingtin and anti-ubiquitin.

Similar content being viewed by others

References

  1. Vonsattel, J.P. et al. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559– 577 (1985).

    Article  CAS  Google Scholar 

  2. Folstein, S.E. Huntington's Disease (Johns Hopkins University Press, Baltimore, 1990).

    Google Scholar 

  3. Hedreen, J.C., Peyser, C.E., Folstein, S.E. & Ross, C.A. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci. Lett. 133, 257– 261 (1991).

    Article  CAS  Google Scholar 

  4. Spargo, E., Everall, I.P. & Lantos, P.L. Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection. J. Neurol. Neurosurg. Psychiatry 56, 487–491 ( 1993).

    Article  CAS  Google Scholar 

  5. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971–983 (1993).

  6. Andrew, S.E. et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet. 4, 398–403 (1993).

    Article  CAS  Google Scholar 

  7. Duyao, M. et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet. 4, 387– 392 (1993).

    Article  CAS  Google Scholar 

  8. Stine, O.C. et al. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum. Mol. Genet . 2, 1547–1549 ( 1993).

    Article  CAS  Google Scholar 

  9. Li, S.H. et al. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11, 985– 993 (1993).

    Article  CAS  Google Scholar 

  10. Strong, T.V. et al. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genet. 5, 259–265 (1993).

    Article  CAS  Google Scholar 

  11. Sharp, A.H. et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14, 1065– 1074 (1995).

    Article  CAS  Google Scholar 

  12. Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493–506 ( 1996).

    Article  CAS  Google Scholar 

  13. Ordway, J.M. et al. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 91, 753–764 ( 1997).

    Article  CAS  Google Scholar 

  14. Wood, J.D., MacMillan, J.C., Harper, P.S., Lowenstein, P.R. & Jones, A.L. Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain. Hum. Mol. Genet. 5, 481–487 (1996).

    Article  CAS  Google Scholar 

  15. White, J.K. et al. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nature Genet. 17, 404–410 (1997).

    Article  CAS  Google Scholar 

  16. Franklin, K.B.J. & Paxinos, G. The Mouse Brain in Stereotaxic Coordinates (Academic Press, San Diego, 1997).

    Google Scholar 

  17. Dragunow, M. et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6, 1053–1057 ( 1995).

    Article  CAS  Google Scholar 

  18. Portera-Cailliau, C., Hedreen, J.C., Price, D.L. & Koliatsos, K.E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775– 3787 (1995).

    Article  CAS  Google Scholar 

  19. Thomas, L.B. et al. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol. 133, 265–272 (1995).

    Article  CAS  Google Scholar 

  20. Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537–548 ( 1997).

    Article  CAS  Google Scholar 

  21. DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993 (1997).

    Article  CAS  Google Scholar 

  22. Paulson, H.L. et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333–344 (1997).

    Article  CAS  Google Scholar 

  23. Skinner, P.J. et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389, 971–974 (1997).

    Article  CAS  Google Scholar 

  24. Borlongan, C.V., Koutouzis, T.K. & Sanberg, P.R. 3-Nitropropionic acid animal model and Huntington's disease. Neurosci. Biobehav. Rev. 21, 289 –293 (1997).

    Article  CAS  Google Scholar 

  25. Brinkman, R.R., Mezei, M.M., Theilmann, J., Almqvist, E. & Hayden, M.R. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am. J. Hum. Genet. 60, 1202–1210 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Kosinski, C.M. et al. Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons. Exp. Neurol. 144, 239–247 (1997).

    Article  CAS  Google Scholar 

  27. Reddy, P.S. & Housman, D.E. The complex pathology of trinucleotide repeats. Curr. Opin. Cell Biol. 9, 364– 372 (1997).

    Article  CAS  Google Scholar 

  28. Matilla, A. et al. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 389, 974– 978 (1997).

    Article  CAS  Google Scholar 

  29. Jou, Y.S. & Myers, R.M. Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum. Mol. Genet. 4, 465– 469 (1995).

    Article  CAS  Google Scholar 

  30. Liu, Y.F., Deth, R.C. & Devys, D.E. SH3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes. J. Biol. Chem. 272, 8121–8124 (1997).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank R. Albin for stimulating discussions and G. Auburger and F.S. Collins for critical reading of the manuscript. We are grateful to M. MacDonald, Y.-F. Liu and R. Myers for generous gifts of HF1, 437 and αHD1 antibodies, respectively. We thank M. Erdos, T. Hernandez, A. Chen, C. Rivas, E. Stockburger and T. Moss for technical assistance. This work was supported in part by USPHS grant NS-28236 to W.O.W.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Danilo A. Tagle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reddy, P., Williams, M., Charles, V. et al. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet 20, 198–202 (1998). https://doi.org/10.1038/2510

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/2510

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing